These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2476543)

  • 1. In-vitro bioassays for cholecystokinin.
    Sjödin L; Nederman T; Olsson PA; Viitanen E
    J Pharm Pharmacol; 1989 Jun; 41(6):402-6. PubMed ID: 2476543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholecystokinin (CCK)-JMV-180 on the CCK receptors of rabbit pancreatic acini and gallbladder smooth muscle.
    Taniguchi H; Nagasaki M; Tamaki H
    Jpn J Pharmacol; 1995 Mar; 67(3):219-24. PubMed ID: 7543168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supramaximal inhibition of cholecystokinin-induced pancreatic amylase release involves desensitization to cytoplasmic Ca2+.
    Nilsson J; Sjödin L; Gylfe E
    Scand J Gastroenterol; 1994 Jun; 29(6):561-8. PubMed ID: 7521537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dopamine on amylase secretion from guinea pig pancreatic acinar cells in vitro.
    Xue BG; Hernandez DE
    Life Sci; 1989; 45(4):311-7. PubMed ID: 2474735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33.
    Solomon TE; Yamada T; Elashoff J; Wood J; Beglinger C
    Am J Physiol; 1984 Jul; 247(1 Pt 1):G105-11. PubMed ID: 6204542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors.
    von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H
    Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of calcium in cholecystokinin-stimulated phosphoinositide breakdown in exocrine pancreas.
    Pandol SJ; Thomas MW; Schoeffield MS; Sachs G; Muallem S
    Am J Physiol; 1985 May; 248(5 Pt 1):G551-60. PubMed ID: 2581457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33.
    Martinez J; Winternitz F; Bodanszky M; Gardner JD; Walker MD; Mutt V
    J Med Chem; 1982 May; 25(5):589-93. PubMed ID: 6177857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of KSG-504, a new cholecystokinin-A-receptor antagonist.
    Yamazaki Y; Akahane M; Kobayashi M; Kitazawa M; Kurashina Y; Iizuka K
    Jpn J Pharmacol; 1993 Oct; 63(2):219-25. PubMed ID: 7506805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cholecystokinin activity by albumin.
    Huang SC; Talkad VD; Fortune KP; Jonnalagadda S; Severi C; Delle Fave G; Gardner JD
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10312-6. PubMed ID: 7479774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.
    Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V
    Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini.
    Liddle RA; Elashoff J; Reeve JR
    Peptides; 1986; 7(5):723-7. PubMed ID: 2432584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of natural glucagon on pancreatic acini: due to contamination by previously undescribed secretagogues.
    Pandol SJ; Sutliff VE; Jones SW; Charlton CG; O'Donohue TL; Gardner JD; Jensen RT
    Am J Physiol; 1983 Nov; 245(5 Pt 1):G703-10. PubMed ID: 6195929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of cholecystokinin and cholinergic agents on calcium transport in isolated pancreatic acinar cells.
    Gardner JD; Conlon TP; Kleveman HL; Adams TD; Ondetti MA
    J Clin Invest; 1975 Aug; 56(2):366-75. PubMed ID: 1150877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norepinephrine stimulates amylase release from pancreatic acini.
    Joehl RJ; Rose RC; Nahrwold DL
    J Surg Res; 1983 Jun; 34(6):543-9. PubMed ID: 6190041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of substance P with dispersed pancreatic acinar cells from the guinea pig. Stimulation of calcium outflux, accumulation of cyclic GMP and amylase release.
    Sjödin L; Conlon TP; Gustavson C; Uddholm K
    Acta Physiol Scand; 1980 May; 109(1):107-10. PubMed ID: 6160730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis toxin stimulates cholecystokinin-induced cyclic AMP formation but is without effect on secretagogue-induced calcium mobilization in exocrine pancreas.
    Willems PH; Tilly RH; de Pont JJ
    Biochim Biophys Acta; 1987 Apr; 928(2):179-85. PubMed ID: 2436669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue.
    Sugg EE; Serra M; Shook JE; Yamamura HI; Burks TF; Korc M; Hruby VJ
    Int J Pept Protein Res; 1988 Jun; 31(6):514-9. PubMed ID: 2457563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.